Global Medical Radioisotopes Competitive Landscape Professional Research Report 2024

Global Medical Radioisotopes Competitive Landscape Professional Research Report 2024

Research Summary

Medical radioisotopes are radioactive substances used in various medical applications, including diagnostic imaging and therapeutic procedures. These isotopes are typically unstable forms of elements that emit radiation as they decay. They are produced in specialized nuclear reactors or particle accelerators and undergo strict quality control measures to ensure their safety and efficacy. In diagnostic imaging, medical radioisotopes are administered to patients either orally or intravenously, allowing healthcare professionals to track their distribution in the body using specialized imaging techniques such as positron emission tomography (PET) or single-photon emission computed tomography (SPECT). Therapeutically, radioisotopes can be used to specifically target and destroy cancer cells in a procedure called radiotherapy. Common medical radioisotopes include technetium-99m, iodine-131, and gallium-67, among others. These radioisotopes play a vital role in medical diagnosis, treatment planning, and monitoring disease progression, offering non-invasive and highly precise imaging and therapeutic options to improve patient care.

According to DIResearch's in-depth investigation and research, the global Medical Radioisotopes market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Medical Radioisotopes include NRG, IRE, ANSTO, NTP Radioisotopes, China National Nuclear Corporation, Rosatom, Nordion, Polatom, Eckert & Ziegler Strahlen etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Medical Radioisotopes. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Medical Radioisotopes market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Medical Radioisotopes market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Medical Radioisotopes industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Medical Radioisotopes Include:

NRG

IRE

ANSTO

NTP Radioisotopes

China National Nuclear Corporation

Rosatom

Nordion

Polatom

Eckert & Ziegler Strahlen

Medical Radioisotopes Product Segment Include:

Tc-99m

Cobalt-60

Iodine Radioisotopes

Medical Radioisotopes Product Application Include:

Nuclear Therapy

Equipment Radioactive Source

Diagnosis

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Medical Radioisotopes Industry PESTEL Analysis

Chapter 3: Global Medical Radioisotopes Industry Porter’s Five Forces Analysis

Chapter 4: Global Medical Radioisotopes Major Regional Market Size and Forecast Analysis

Chapter 5: Global Medical Radioisotopes Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Medical Radioisotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Medical Radioisotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Medical Radioisotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Medical Radioisotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Medical Radioisotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Medical Radioisotopes Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Medical Radioisotopes Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources